Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water.

نویسنده

  • Vincent Cottin
چکیده

P ulmonary hypertension (PH), group III of the international aetiological classification [1], is a frequent and severe complication of interstitial lung diseases (ILDs), especially idiopathic pulmonary fibrosis (IPF), the syndrome of combined pulmonary fibrosis and emphysema, ILD associated with connective tissue disease, sarcoidosis, pulmonary Langerhans cell histiocytosis and, rarely, other ILDs [2–6]. Although its prevalence varies widely between these conditions, PH, when present, dramatically impacts morbidity and survival.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Statins and Pulmonary Hypertension in Chronic Obstructive Lung Disease

Chronic obstructive lung disease (COPD) is a chronic multisystem disease with a considerable burden. One of its most common complications is pulmonary artery hypertension (PAH). It has been demonstrated that the development of PAH is correlated with decreased quality of life and survival. Different medications have been proposed for the treatment of PAH, among which one can name statins. Howeve...

متن کامل

The Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease

Introduction: Pulmonary involvement is the most common cause of mortality and disability in patients with systemic sclerosis and it significantly affects the quality of life in these patients. Therefore, early diagnosis and treatment of pulmonary involvement seems necessary in patients with SSc. In this study, we aimed to assess the health-related quality of life (HRQoL) in patients with Sclero...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The European respiratory journal

دوره 41 4  شماره 

صفحات  -

تاریخ انتشار 2013